XML 21 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities:    
Net income (loss) $ 7,569 $ (35)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Release of valuation allowance on deferred tax assets (6,397) 0
Investment impairment 0 11,000
Deferred taxes 5,644 2,149
Depreciation of fixed assets and amortization of intangible assets 42,626 48,490
Amortization of debt issuance costs and debt discount 1,154 1,739
Amortization of cloud computing arrangements 663 186
Stock-based compensation 28,497 30,025
Changes in contingent consideration (614) (3,032)
Net accretion of discount on available-for-sale investments (927) (3,444)
Other net gains 0 (5,887)
Changes in operating assets and liabilities:    
Accounts receivable, net (12,074) (1,046)
Inventories, net 8,451 (22,871)
Prepaid expenses and other assets 378 (15,377)
Accounts payable 2,248 9,344
Accrued expenses 1,563 (14,675)
Other liabilities 4,359 10,905
Net cash provided by operating activities 83,140 47,471
Investing activities:    
Acquisition of GQ Bio Therapeutics GmbH (net of cash acquired) (335) (16,702)
Purchases of fixed assets (4,060) (11,245)
Purchases of available-for-sale investments (3,905) (74,685)
Sales of available-for-sale investments 39,500 140,416
Purchase of convertible notes receivable investment 0 (1,250)
Net cash provided by investing activities 31,200 36,534
Financing activities:    
Proceeds from exercises of stock options 459 0
Proceeds from shares issued under employee stock purchase plan 1,722 1,569
Payment of employee withholding taxes on restricted stock unit vests (7,848) (5,466)
Purchase of treasury stock, inclusive of broker fees (50,045) (50,039)
Excise taxes paid on treasury stock repurchases 1,336 0
Repayment of Term loan A facility 0 (6,563)
Repayment of Revolving Credit Facility (10,000) 0
Net cash used in financing activities (67,048) (60,499)
Effect of exchange rate changes on cash and cash equivalents 38 204
Net increase in cash and cash equivalents 47,330 23,710
Cash and cash equivalents, beginning of period 158,545 276,774
Cash and cash equivalents, end of period 205,875 300,484
Supplemental cash flow information:    
Cash paid for interest 6,171 7,687
Net cash paid for income taxes 910 8,233
Non-cash investing and financing activities:    
Fixed assets included in accounts payable and accrued liabilities 1,506 1,431
Excise tax on treasury stock repurchases included in accrued liabilities $ 403 $ 354